hVIVO Announces New Canary Wharf Address
Company Announcements

hVIVO Announces New Canary Wharf Address

Open Orphan Plc (GB:HVO) has released an update.

hVIVO plc, previously known as Open Orphan plc, a leading specialist contract research organisation in the infectious and respiratory disease sector, has announced the change of its registered address to a new location in Canary Wharf, London. The company, renowned for conducting human challenge clinical trials, boasts the world’s largest commercial human challenge trial unit and offers a comprehensive range of services including drug development, clinical consultancy, and volunteer recruitment for trials.

For further insights into GB:HVO stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks UK Auto-Generated NewsdeskhVIVO Plc to Present at London Healthcare Conference
TipRanks UK Auto-Generated NewsdeskhVIVO Incentivizes Leadership with New LTIP
TipRanks UK Auto-Generated NewsdeskOpen Orphan Plc Triumphs in RSV Antiviral Trial
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App